Thank you for visiting
TREXIMET.com

You are about to leave the TREXIMET® (sumatriptan/naproxen sodium) website and enter a website operated by an independent third party. The links to the third-party websites contained in TREXIMET.com are provided for your convenience. Pernix Therapeutics does not control the opinions or claims contained in any third-party website linked to TREXIMET.com. The policies and practices of third-party websites may differ from ours.

Would you like to leave TREXIMET.com?

Treximet (sumatriptan/naproxen sodium) | Migraines are complex. Keep it simple.
Patients may pay as little as $25* Get a savings card now!

TREXIMET® provides:

  • Reduced need for rescue medication when compared with patients taking sumatriptan alone1,2
  • Superior sustained pain-free results
    2 to 24 hours vs sumatriptan alone1,2
  • Superior pain relief at 2 hours vs sumatriptan alone1,2
  • Dual mechanism of action (sumatriptan/naproxen sodium)1
  • RT Technology™ (rapid release tablets) formulation3

The exact mechanism of action is not known.

The term RT Technology™ is a trademark of GlaxoSmithKline.

Back to Top